VANGUARD GROUP INC - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 33 filers reported holding VIVOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$118,144
-67.6%
615,015
-13.9%
0.00%
Q2 2023$364,194
+48.5%
714,106
-0.7%
0.00%
Q1 2023$245,308
-16.6%
719,167
-1.7%
0.00%
Q4 2022$294,200
-38.1%
731,842
+0.1%
0.00%
Q3 2022$475,000
-47.0%
731,378
+5.2%
0.00%
Q2 2022$897,000
-51.8%
695,0510.0%0.00%
Q1 2022$1,862,000
+24.8%
695,051
+4.8%
0.00%
Q4 2021$1,492,000
-40.2%
663,253
+7.5%
0.00%
Q3 2021$2,494,000
+31.3%
617,251
+60.8%
0.00%
Q2 2021$1,900,000383,8910.00%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 162,500$804,0000.46%
BARD ASSOCIATES INC 215,500$1,067,0000.35%
Millrace Asset Group, Inc. 93,993$465,0000.24%
Archon Capital Management LLC 215,000$1,064,0000.12%
Penn Capital Management Company, LLC 223,403$1,106,0000.11%
GRIFFIN ASSET MANAGEMENT, INC. 49,500$245,0000.03%
K2 PRINCIPAL FUND, L.P. 64,746$320,0000.03%
Walleye Capital LLC 150,000$743,0000.02%
WMS Partners, LLC 16,667$153,0000.02%
Avalon Investment & Advisory 189,739$939,0000.02%
View complete list of VIVOS THERAPEUTICS INC shareholders